Nathaniel Rickles

Dr. Nathaniel Rickles


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2018 in Journal of Medical Internet Research
Verified
Journal Article
Open access
TBTimothy W Bickmore
Timothy W Bickmore
HTHa Trinh
Ha Trinh
SOStefan Olafsson
Stefan Olafsson
TOTeresa K O'LEary
Teresa K O'LEary
RAReza Asadi
Reza Asadi
RCRicardo Cruz
Ricardo Cruz
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Conversational assistants, such as Apple’s Siri, Amazon’s Alexa, and Google Assistant, are ubiquitous, and are beginning to be used as portals for medical services. However, the potential safety issues of using conversational assistants for medical information by patients and consumers are not understood. Objective: To determine the prevalence and nature of harm that could result from patients or consumers using conversational assistants for medical information. Methods: Participants were given medical problems to pose to Siri, Alexa, or Google Assistant, and asked to determine an action to take based on information from the system. Assignment of tasks and systems were randomized across participants, and participants queried the conversational assistants in their own words, making as many attempts as needed, until they either reported an action to take or gave up. Participant reported actions for each medical task were rated for patient harm using an AHRQ harm scale. Results: Fifty-four (54) subjects completed the study. Subjects were on average 41.5±17.7 years old, 53.7% female, 57.4% Caucasian, 50.0% college educated. Only 14.8% reported using a conversational assistant regularly, 40.7% had never used one, and 44.4% had tried one “a few times”, while 81.5% reported using computers regularly. Subjects were only able to complete 42.6% (168) of their 394 tasks, but of those, 29.2% (49) of reported actions could have resulted in some degree of patient harm, including 16.1% (27) that could have resulted in death. Conclusions: Reliance on conversational assistants for actionable medical information represents a safety risk for patients and consumers. Patients should be cautioned to not use these technologies for answers to medical questions they intend to act on without further consultation from a healthcare provider. Clinical Trial: N/A

19 August 2019 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
SGStephanie Gernant
Stephanie Gernant
JBJennifer L. Bacci
Jennifer L. Bacci
CUCharlie Upton
Charlie Upton
SFStefanie Ferreri
Stefanie Ferreri
SMStephanie McGrath
Stephanie McGrath
MSMarie Smith
Marie Smith

1 August 2019 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
NRNathaniel Rickles
Nathaniel Rickles
AHAmy L. Huang
Amy L. Huang
MGMichelle B. Gunther
Michelle B. Gunther
WCWinney J. Chan
Winney J. Chan

30 June 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CLChongliang Luo
Chongliang Luo
KCKun Chen
Kun Chen
RDRiddhi Doshi
Riddhi Doshi
NRNathaniel Rickles
Nathaniel Rickles
YCYong Chen
Yong Chen
RARobert H. Aseltine
Robert H. Aseltine
Background: Suicides and opioid overdose deaths are among the most pressing public health concerns in the US. However direct evidence for the association between opioid use and suicidal behavior is limited. The objective of this article is to examine the association between frequency and dose of prescription opioid use and subsequent suicide attempts.Methods and findings: This retrospective cohort study analyzed 4 years of statewide medical claims data from the Connecticut All-Payer Claims Database. Commercially insured adult patients in Connecticut (n = 842,773) who had any medical claims beginning in January 2012 were followed through December 2015. The primary outcome was suicide attempt identified using International Classification of Diseases (ICD 9) diagnosis codes. Primary predictor variables included frequency of opioid use, which was defined as the number of months with claims for prescription opioids per year, and strength of opioid dose, which was standardized using morphine milligram equivalent (MME) units. We also controlled for psychiatric and medical comorbidities using ICD 9 codes. We used Cox proportional hazards regression to examine the association between frequency, dose, and suicide attempts, adjusting for medical and psychiatric comorbid conditions. Interactions among measures of opioid use and comorbid conditions were analyzed.In this cohort study with follow-up time up to 4 years (range = 2–48 months, median = 46 months), the hazard ratios (HR) from the time-to-event analysis indicated that patients prescribed opioid medications for at least 6 months during the past year and at 20–50 MME levels or higher had 4.44 (95% CI: [3.71, 5.32]) to 7.23 (95% CI: [6.22, 8.41]) times the risk of attempted suicide compared to those not prescribed opioids. Risk of suicide attempt was sharply elevated among patients with psychiatric conditions other than anxiety who were prescribed more frequent and higher opioid doses. In contrast, more frequent and higher doses of prescription opioids were associated with lower risk of suicide attempts among patients with medical conditions necessitating pain management.This study is limited by its exclusive focus on commercially insured patients and does not include patients covered by public insurance. It is also limited to patients’ receipt of prescription opioids and does not take into account opioids obtained through other means, nor does it include measures of actual patient opioid use.Conclusions: This analysis provides evidence of a complex relationship among prescription opioids, mental health, pain and other medical comorbidities, and suicide risk. Findings indicate the need for proactive suicide surveillance among individuals diagnosed with affective or psychotic disorders who are receiving frequent and high doses of opioids. However, appropriate opioid treatment may have significant value in reducing suicide risk for those without psychiatric comorbidities.

16 September 2019 in Pharmacy
Verified
Journal Article
Open access
PDF file
NRNathaniel Rickles
Nathaniel Rickles
AWAlbert Wertheimer
Albert Wertheimer
YHYifan Huang
Yifan Huang
Nearly 44 million Americans are affected by mental illness every year. Many individuals, however, are not diagnosed and/or do not receive treatment. The present manuscript reviews the incidence of mental illness, the continuum from mental wellness to mental illness, and the role of the pharmacy staff in helping individuals manage different mental health needs. In particular, there is discussion of stigma of mental illness that those with mental health needs experience by those around them including health professionals such as pharmacy staff. One way to resolve such stigma is through training such as Mental Health First Aid (MHFA). The paper reviews key aspects of MHFA, the evidence supporting MHFA, and how MHFA relates specifically to pharmacy practice and services. A conceptual framework for MHFA and its relationship to individual factors, attitudes, behaviors, and outcomes. Lastly, a discussion is presented that briefly compares MHFA to other similar approaches to helping those in mental health crises, the limits of what is known about MHFA, and what future research might explore to better understand the outcomes of pharmacy staff providing mental health education, support, and referral to care.

2 September 2020 in The Journal of Behavioral Health Services & Research
Verified
Journal Article
Closed access
PDF file
NRNathaniel Rickles
Nathaniel Rickles
Anthony W OlsonAnthony W Olson
Anthony W Olson
PTPaul D. Tieger
Paul D. Tieger
Jon SchommerJon Schommer
Jon Schommer
LBLawrence Brown
Lawrence Brown